Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Challenges in treating elderly lung cancer patients

SIOG 2019

14 - 16 Nov 2019

Published: 28 Nov 2019

Views: 1235

Rating:

Save

Prof Mike Jaklitsch - Harvard Medical School, Boston, USA

Prof Mike Jaklitsch speaks to ecancer at the SIOG 2019 meeting in Geneva about some of the challenges involved with treating elderly lung cancer patients.

He explains that with modern techniques improving the invasiveness of operations, the pool of patients who can receive these surgeries as increased.

Prof Jaklitsch also highlights the importance of smoking cessation prior to surgery.

This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.

Related Videos

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale Tomasini

ESMO and WCLC: Latest developments in EGFR mutated NSCLC ( Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale Tomasini )

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients

Prof Salomon Manier - Hospital Center University De Lille, Lille, France

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients ( Prof Salomon Manier - Hospital Center University De Lille, Lille, France )

ESMO 2024: Latest in EGFR mutated NSCLC

Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip

ESMO 2024: Latest in EGFR mutated NSCLC ( Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip )

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom

ASCO 2024: Lung cancer highlights ( Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom )

Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes

Prof Jean-Marc Classe - Nantes Université, Nantes, France

Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes ( Prof Jean-Marc Classe - Nantes Université, Nantes, France )

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC

Prof Nicolas Girard - Institut Curie, Paris, France

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Developments in surgery for early stage lung cancer

Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland

Developments in surgery for early stage lung cancer ( Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland )

More from ecancer